| 发明名称 |
ORAL LIQUID ALENDRONATE FORMULATIONS |
| 摘要 |
Disclosed is a therapy protocol for treating and for preventing bone loss in patients who have difficulty in swallowing by administering a liquid formulation of alendronate which can be easily swallowed. Also described are pharmaceutical dosage forms of a syrup, aqueous solution, a solution formed from a reconstituted powder, of alendronate, for carrying out the therapeutic method.
|
| 申请公布号 |
CA2190148(A1) |
申请公布日期 |
1995.11.23 |
| 申请号 |
CA19952190148 |
申请日期 |
1995.05.12 |
| 申请人 |
MERCK & CO., INC. |
发明人 |
BRENNER, GERALD S.;KATDARE, ASHOK V.;PRETZER, DENISE;WHITEFORD, DONNA T. |
| 分类号 |
A61K9/08;A61K9/00;A61K9/14;A61K31/66;A61K31/663;A61K47/12;A61P19/00;A61P19/08;A61P19/10;A61P29/00;A61P35/00;A61P43/00;(IPC1-7):A61K31/663 |
主分类号 |
A61K9/08 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
